Concepedia

Chunlong Ma

CM

Statistics

Publications

72

Citations

5.8K

H-Index

39

Active since

2004

Affiliations

University of Arizona(Current)

Northwestern University

Howard Hughes Medical Institute

University of Pennsylvania

University of California, San Francisco

Chunlong Ma is an author at University of Arizona specializing in medicine, virology, and drug discovery.

ORCID

Top concepts

Publications per year

2004–2022

72

Publications

72

Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

Chunlong Ma, M. Sacco, Brett L. Hurst et al. · Cell Research · 2020 · 870 citations · Full text

Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M <sup>pro</sup> and cathepsin L

M. Sacco, Chunlong Ma, Panagiotis Lagarias et al. · Science Advances · 2020 · 390 citations · Full text

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

Britton Boras, Rhys Jones, Brandon J. Anson et al. · Nature Communications · 2021 · 284 citations · Full text

Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors

Chunlong Ma, Yanmei Hu, Julia A. Townsend et al. · ACS Pharmacology & Translational Science · 2020 · 264 citations · Full text

Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus

Jun Wang, Yibing Wu, Chunlong Ma et al. · Proceedings of the National Academy of Sciences · 2013 · 222 citations · Full text

, , +18

1–5 of 72